Effect of Therapeutic Class on Generic Drug Substitutions (U01)
ArchivedFood and Drug Administration
Description
The purpose of this study is to rank order generic drugs based on therapeutic class with low generic substitution/acceptance rate and analyze factors affecting the generic substitution in each therapeutic class. The outcome of this study will help identify research needs and align FDA’s regulatory science efforts to monitor and ensure successful generic substitution and thereby assure the public about generic drug safety and efficacy.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
- Unrestricted
Contact
Martin Bernard <br/>Grants Management Specialist <br/>Phone 240-402-7564
Martin.Bernard@fda.hhs.gov
- PostedApr 29, 2014
- ClosesJun 21, 2014
- Award floor$350,000
- Award ceiling$400,000
- Program funding$400,000
- Expected awards2
- CFDA93.103
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro